Domestic market could ‘double’ on back of driving law reform: Bioxyne by Adam Sheldon March 25, 2026March 25, 2026 Pending changes to roadside drug testing laws could double the size of the Australian medicinal cannabis […]
Court adjourns Montu case again as proceedings approach second anniversary by Steve Jones March 24, 2026March 25, 2026
Don’t repeat the mistakes that caused the benzo and opioid crises, addiction specialist warns by Adam Sheldon March 23, 2026March 25, 2026
More job losses at Montu as sales chief Craig Thompson departs by Steve Jones March 19, 2026March 19, 2026
Industry hits back at Lancet paper for ‘rifling through the bones of an old, musty evidence base’ by Steve Jones March 19, 2026March 19, 2026
Cape to Cape for Cannabis nears as organisers urge final registrations by Adam Sheldon March 19, 2026June 8, 2026
The People’s Plant pushes toward $1.5m as CSF offer nears close by Adam Sheldon March 19, 2026March 19, 2026
Lancet clinical review paper: why absence of evidence is not evidence of absence by Andrew Proudfoot March 18, 2026March 18, 2026
Meet the appointed members of the scheduling committee who could shape THC’s regulatory future by Adam Sheldon and Steve Jones March 18, 2026March 19, 2026
